Wu Y - Search Results

1

Connective Tissue Growth Factor in Digestive System Cancers: A Review and Meta-Analysis.

Zhao F, Li C, Wu Y, Xia J, Zeng M, Li T, Xie K. Zhao F, et al. Among authors: wu y. Biomed Res Int. 2020 Dec 27;2020:8489093. doi: 10.1155/2020/8489093. eCollection 2020. Biomed Res Int. 2020. PMID: 33426067 Free PMC article.

2

[Prenatal gene diagnosis of 200 fetuses at high risk of osteogenesis imperfect].

Zhao XL, Gao JS, Li LL, Li S, Wang H, Xiao JF, Zhang J, Mi H, Yang YJ, Zhao FY, Guan X, Cao YX, Wu YY, Lu CX, Yang T, Zhang X. Zhao XL, et al. Among authors: wu yy. Zhonghua Yi Xue Za Zhi. 2019 Nov 12;99(42):3328-3334. doi: 10.3760/cma.j.issn.0376-2491.2019.42.011. Zhonghua Yi Xue Za Zhi. 2019. PMID: 31715670 Chinese.

3

Prognostic Value of the Serum HER2 Extracellular Domain Level in Breast Cancer: A Systematic Review and Meta-Analysis.

Wu Y, Li L, Zhang D, Ma F. Wu Y, et al. Cancers (Basel). 2022 Sep 20;14(19):4551. doi: 10.3390/cancers14194551. Cancers (Basel). 2022. PMID: 36230471 Free PMC article. Review.

4

Efficacy and safety of trastuzumab with or without a tyrosine kinase inhibitor for HER2-positive breast cancer: A systematic review and meta-analysis.

Li L, Zhang D, Wu Y, Wang J, Ma F. Li L, et al. Among authors: wu y. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188969. doi: 10.1016/j.bbcan.2023.188969. Epub 2023 Aug 26. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37640146 Review.

5

Clinical characteristics associated with efficacy and prognosis among patients treated with PD-1/PD-L1 inhibitors for early-stage triple-negative breast cancers: A meta-analysis.

Wei Y, Wu Y, Luo Y, Ma F. Wei Y, et al. Among authors: wu y. Crit Rev Oncol Hematol. 2024 Apr;196:104309. doi: 10.1016/j.critrevonc.2024.104309. Epub 2024 Feb 28. Crit Rev Oncol Hematol. 2024. PMID: 38423376 Review.

6

Efficacy of PARP Inhibitor, Platinum, and Immunotherapy in BRCA-Mutated HER2-Negative Breast Cancer Patients: A Systematic Review and Network Meta-Analysis.

Sun W, Wu Y, Ma F, Fan J, Qiao Y. Sun W, et al. Among authors: wu y. J Clin Med. 2023 Feb 17;12(4):1588. doi: 10.3390/jcm12041588. J Clin Med. 2023. PMID: 36836123 Free PMC article. Review.

7

Optimal Choice as First-Line Therapy for Patients with Triple-Negative Breast Cancer: A Bayesian Network Meta-Analysis.

Han Y, Wang J, Wu Y, Xu H, Wang Y, Xu B. Han Y, et al. Among authors: wu y. Curr Oncol. 2022 Nov 25;29(12):9172-9180. doi: 10.3390/curroncol29120718. Curr Oncol. 2022. PMID: 36547132 Free PMC article. Review.

8

New insights into HER2-low breast cancer brain metastasis: A retrospective analysis.

Xu H, Wang Y, Li L, Han Y, Wu Y, Sa Q, Xu B, Wang J. Xu H, et al. Among authors: wu y. Breast. 2024 Feb;73:103669. doi: 10.1016/j.breast.2023.103669. Epub 2024 Jan 1. Breast. 2024. PMID: 38176304 Free PMC article.

9

HER2-low breast cancer: Novel detections and treatment advances.

Wu Y, Zhong R, Ma F. Wu Y, et al. Crit Rev Oncol Hematol. 2023 Jan;181:103883. doi: 10.1016/j.critrevonc.2022.103883. Epub 2022 Nov 23. Crit Rev Oncol Hematol. 2023. PMID: 36427769 Review.

10

Advances in medical treatment of breast cancer in 2022.

Zhai J, Wu Y, Ma F, Kaklamani V, Xu B. Zhai J, et al. Among authors: wu y. Cancer Innov. 2023 Feb 21;2(1):1-17. doi: 10.1002/cai2.46. eCollection 2023 Feb. Cancer Innov. 2023. PMID: 38090370 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85,905 results

Search Page

Filters